Navigation Links
Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
Date:7/1/2008

Jury verdict in Montgomery County Circuit Court awards $33 million in

compensatory damages Jury decides in favor of Novartis and rejects claims for punitive damages NPC maintains it reported true and accurate prices and will file appeal

EAST HANOVER, N.J., July 1 /PRNewswire/ -- Novartis Pharmaceuticals Corporation (NPC) today announced it will appeal a verdict in the Montgomery County Circuit Court. Novartis disputes the State of Alabama's claims that the prices provided by NPC to reporting services resulted in overpayment to pharmacists and doctors in the Alabama State Medicaid system.

NPC was among 73 pharmaceutical manufacturers named in a lawsuit filed in 2005 by the Alabama Attorney General, claiming that the average wholesale price (AWP) and wholesale acquisition cost (WAC) provided by pharmaceutical companies to price reporting services resulted in overpayment to pharmacists and doctors in the State Medicaid system. The jury rejected the State's claims for punitive damages but decided against NPC on the State's claims for compensatory damages, awarding $33 million.

NPC believes Alabama's claims were unfounded because it reported true and accurate prices, based on terms that have been known and used by all participants in pharmaceuticals markets, including Alabama Medicaid, for more than 30 years.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "to Appeal," "will," "believes," or similar expressions, or by express or implied discussions regarding the potential outcome of the forthcoming appeal in the litigation which is the subject of this press release, or of the potential outcome of any other pricing litigation. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materia
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
2. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
3. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
4. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
6. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
7. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
8. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
11. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... According to a new market research report "Machine ... ultrasound emission, lubricating oil analysis, corrosion monitoring, motor ... Global Forecast to 2014 - 2020", published by ... to reach $2.50 at a CAGR of 7.16% ... data Tables and 57 Figures spread through 353 ...
(Date:7/25/2014)... As reported by the New Orleans Advocate ... (7/3), the state of Louisiana has recently seen a ... than cocaine. Officials believe the increase is due to a ... of marijuana. However, both doctors and police confirm that that ... to call it “poison,” doctors have acknowledged that the Louisiana ...
(Date:7/25/2014)... Society of America (GSA) the nation,s ... aging has chosen Heather M. Young, PhD, ... as the 2014 recipient of the Doris Schwartz ... presented by GSA,s Health Sciences Section, is given ... of outstanding and sustained contribution to gerontological nursing ...
(Date:7/25/2014)... As reported by People Magazine in the ... Shore and Getting Sober (7/15), one of the most ... spoken out to the public about his personal transformation. Now, ... Situation admits that moving on with his life was a ... other drugs in 2012 and even spent some time in ...
(Date:7/25/2014)... Merrill Corporation ( http://www.merrillcorp.com ), ... the financial, legal, healthcare and other corporate markets, ... Merrill DataSite, has been recognized as the “Technology ... the M&A Awards 2014 event. , ... management teams, advisors and financiers as they demonstrate ...
Breaking Medicine News(10 mins):Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Louisiana Recognizes Dangers of Synthetic Marijuana 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:Merrill DataSite Recognized as “Technology Provider of the Year” by GrowthBusiness at the M&A Awards 2014 Event 2
... (HealthDay News) -- Obesity and insulin resistance constitute a greater ... to a new study that found drinking modest amounts of ... For their study, published online May 23 in ... to either abstain from alcohol or drink one (women) or ...
... Mathematical models analyzing how a cholera outbreak ... the most effective vaccination strategies for preventing future ... The mathematical models employed to analyze a ... that mass vaccinations deployed strategically could prevent future ...
... impairment is evident early on in preschool children with ... children. Age of onset of first seizure is a ... first to evaluate cognitive impairment in children age three ... , a journal published by Wiley-Blackwell on behalf of ...
... June 2, 2011 In a multicenter ... found that higher doses of stereotactic radiation therapy ... patients with low-to-intermediate-risk prostate cancer. Results of ... Clinical Oncology , showed that stereotactic body radiation ...
... WEDNESDAY, June 1 (HealthDay News) -- People who become very afraid ... attack also seem to have more inflammation, an indicator that they ... less fearful, a small British study suggests. The finding, published ... us of the connection between the mind and the body," said ...
... Clinical Cardiology reveals that in men with ... libido, erectile dysfunction, and sexual performance. Chronic heart failure ... fatigue and exercise intolerance. HF patients experience decreased libido ... of pacemaker that paces the right and left ventricle, ...
Cached Medicine News:Health News:Obesity Greater Risk for Fatty Liver Than Alcohol, Study Finds 2Health News:UF researchers suggest cholera vaccination strategies for Zimbabwe 2Health News:Cognitive impairment seen in preschool children with epilepsy 2Health News:Higher doses of radiation in fewer treatments proved safe, effective for low-risk prostate cancer 2Health News:Fear of Dying During Heart Attack May Make Matters Worse 2Health News:Fear of Dying During Heart Attack May Make Matters Worse 3
(Date:7/25/2014)... July 25, 2014  CVS Caremark Corporation (NYSE: ... on Tuesday, August 5, 2014, at 8:30 a.m. (EDT) ... 2014 financial results. An audio webcast of ... Investor Relations portion of the CVS Caremark website for ... http://info.cvscaremark.com/investors . This webcast will be archived and available ...
(Date:7/25/2014)... , July 25, 2014 Cardinal Health ... community pharmacies as winners of its prestigious Independent Pharmacy ... Conference , one of the nation,s largest gatherings of ... winners – family-owned pharmacies from Ohio ... Texas – were selected for implementing exceptionally ...
(Date:7/25/2014)... 2014 According to a new ... China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern ... Trends and Forecast (Value and Volume), 2013 - 2019", ... billion in 2012 and is expected to grow at ... reach USD 32.24 billion in 2019. Browse ...
Breaking Medicine Technology:Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4
... 20 Accuray, Inc., (Nasdaq: ARAY ), ... announced today that it ranked number 113 on ... fastest growing technology, media, telecommunications, life sciences and clean ... percentage of fiscal year revenue growth during the period ...
... ViroPharma Incorporated,s (Nasdaq: VPHM ) third quarter ... Wednesday, October 27, 2010 before the open of the U.S. ... call and live audio webcast at 9:00 a.m. Eastern Time ... will discuss the 2010 third quarter financial results and other ...
Cached Medicine Technology:Accuray Ranked Number 113 Fastest Growing Company in North America on Deloitte's 2010 Technology Fast 500™ 2Accuray Ranked Number 113 Fastest Growing Company in North America on Deloitte's 2010 Technology Fast 500™ 3ViroPharma to Release 2010 Third Quarter Financial Results on October 27, 2010 2
For the direct quantitative determination of low density lipoprotein cholesterol (LDL-C) in human serum or plasma. For in vitro diagnostic use only....
Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: male: 3.5 - 7.0 mg/dL and female: 2.5 - 6.0 mg/dL. Available with calibrator and number of test 500....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
The assay kit is for determination of uric acid in serum or urine. Wavelength: 600 nm. Linear range: up to 80 mg/dL....
Medicine Products: